Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Medical Genetics · BRCA Variant of Uncertain Significance

What is a VUS (Variant of Uncertain Significance) in BRCA?

At a Glance

A Variant of Uncertain Significance (VUS) in BRCA testing means a genetic change was found, but it is unknown if it increases cancer risk. Over 90% of VUS are eventually reclassified as harmless. Doctors recommend against making major surgical or treatment decisions based solely on a VUS.

Getting genetic test results can be an anxious experience, especially if you see the words “Variant of Uncertain Significance” (VUS) on your report. A VUS simply means that the laboratory found a change in your BRCA1 or BRCA2 gene, but they do not yet have enough scientific evidence to know if this change increases your risk of cancer, or if it is just a normal, harmless variation in your DNA [1].

How is a VUS Managed Clinically?

When a genetic test returns a VUS, the result is inconclusive. However, major medical guidelines advise doctors to manage your care as if the result were negative [2][3]. Because the risk is unproven, doctors do not use a VUS to guide your cancer prevention plan [2]. This means that major, irreversible medical decisions—such as preventative surgeries (mastectomy or oophorectomy)—should never be made based solely on a VUS result [2].

Additionally, if you have already been diagnosed with cancer, a VUS is generally not used to make active treatment decisions, such as determining if you qualify for precision therapies like PARP inhibitors [4].

Instead, your cancer screening, prevention, and treatment plans will be based entirely on your personal medical history and your family’s history of cancer [3][5]. If your family history suggests a high risk of cancer, you may still be advised to undergo extra screening (such as breast MRIs), but this recommendation would be due to your family tree, not the VUS result [3]. Furthermore, because the variant’s risk is unknown, testing family members (like children or siblings) for the VUS is usually not recommended unless it is part of a research study to help clarify the variant’s meaning.

Will My VUS Ever Be Clarified?

Yes, it is very common for a VUS to be reclassified as researchers gather more genetic data from families around the world [4]. Over time, genetic laboratories update their databases and can often definitively determine whether a variant is harmful (pathogenic) or harmless (benign).

Here is what research shows about how these variants change over time:

  • Many variants are eventually reclassified: In one large study, about 25% of VUS results were eventually reclassified as more information became available [6].
  • Most are harmless: When a VUS is reclassified, the vast majority—over 90%—are downgraded to “benign” or “likely benign,” meaning they do not cause an increased risk of cancer [6]. Only about 9% of reclassified variants are upgraded to pathogenic [6].

Waiting in “limbo” for a variant to be reclassified can be emotionally frustrating. Because it can take months or even years for a laboratory to reclassify a VUS [6], it is important to stay in touch with your genetic counselor or doctor [4]. Many labs will automatically notify the medical provider who ordered the test if your variant’s status ever changes.

However, because doctors sometimes retire or you might change clinics, it is a good idea to take ownership of your follow-up. Always ask for a physical or digital copy of your genetic test report. Keeping this report ensures you always have the name of the testing laboratory and the exact code for your variant. You can also ask your care team how often you should check back for updates, such as during an annual check-in.

Common questions in this guide

Should I have preventative surgery if I have a VUS on my BRCA test?
No. Major medical guidelines advise that irreversible decisions like a mastectomy or oophorectomy should never be made based solely on a VUS result. Because the risk is unproven, your preventative care should be based on your personal and family medical history instead.
Will my VUS ever be reclassified?
Yes, it is common for a VUS to be reclassified over time as researchers gather more genetic data from families. When a VUS is reclassified by testing laboratories, over 90% are downgraded to benign or harmless.
Should my family members get tested for my VUS?
Testing family members for your specific VUS is usually not recommended. Because the true risk of the genetic variant is unknown, testing relatives will not provide them with clear answers about their cancer risk unless it is part of a research study.
How will a VUS affect my cancer treatment?
A VUS is not used to make active cancer treatment decisions, such as determining if you qualify for targeted therapies like PARP inhibitors. Your treatment plan will rely on other confirmed factors, such as your personal health and family history of cancer.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my family history alone, what should my cancer screening schedule look like?
  2. 2.Who will contact me if my VUS is reclassified, and how often should I check in with you for updates?
  3. 3.What is the exact name or code of my VUS, and can I have a physical or digital copy of my genetic test report for my personal records?
  4. 4.Is there a genetic registry or research study I can join that might help scientists classify my specific variant sooner?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    Variant reclassification and clinical implications.

    Walsh N, Cooper A, Dockery A, O'Byrne JJ

    Journal of medical genetics 2024; (61(3)):207-211 doi:10.1136/jmg-2023-109488.

    PMID: 38296635
  2. 2

    Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes.

    Nielsen SM, Russell EM, Ellsworth RE, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2025; (23(6)):248-254 doi:10.6004/jnccn.2025.7011.

    PMID: 40306323
  3. 3

    The influence of BRCA variants of unknown significance on cancer risk management decision-making.

    Chern JY, Lee SS, Frey MK, et al.

    Journal of gynecologic oncology 2019; (30(4)):e60 doi:10.3802/jgo.2019.30.e60.

    PMID: 31074248
  4. 4

    Reclassification of BRCA1 and BRCA2 Variants of Unknown Significance in a Turkish Cohort; A Single-Center, Retrospective Study.

    Özer L, Aktuna S, Ünsal E

    European journal of breast health 2025; (21(4)):295-300 doi:10.4274/ejbh.galenos.2025.2025-5-2.

    PMID: 40851390
  5. 5

    Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.

    Makhnoon S, Bednar EM, Krause KJ, et al.

    Clinical genetics 2021; (100(2)):119-131 doi:10.1111/cge.13966.

    PMID: 33843052
  6. 6

    Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.

    Mersch J, Brown N, Pirzadeh-Miller S, et al.

    JAMA 2018; (320(12)):1266-1274 doi:10.1001/jama.2018.13152.

    PMID: 30264118

This page explains Variant of Uncertain Significance (VUS) results for educational purposes only. Your genetic counselor or oncologist is the best source for interpreting your specific genetic test report and guiding your care.

Get notified when new evidence is published on Hereditary breast and/or ovarian cancer syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.